ISSWSH Symposium on Vulvar, Vestibular and Vaginal Changes from GSM and Improvement with Pharmaceutical Treatment
Friday, March 8, 2019
07:00 a.m. – 08:00 a.m.
07:00 a.m. – 07:12 a.m.
Introduction/Embryology and physiology of the vulva, vestibule and vagina
Noel N. Kim, PhD, IF
07:12 a.m. – 07:24 a.m.
Structural/physiologic changes to the vulva, vestibule and vagina resulting from GSM
James A. Simon, MD, CCD, NCMP, FACOG, IF
07:24 a.m. – 07:36 a.m.
Contemporary FDA-approved pharmacologic treatment options: risks and benefits
Alyse Kelly-Jones, MD, IF
07:36 a.m. – 07:48 a.m.
Structural/physiologic changes to the vulva, vestibule and vagina with treatment
Irwin Goldstein, MD, IF
07:48 a.m. – 08:00 a.m.
Participants must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.
NOTE: If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the International Society for the Study of Women’s Sexual Health, Inc (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American
Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.